Pozelimab+Cemdisiran Superior to Ravulizumab in Hemoglobinuria
07 Dec 2024 //
GLOBENEWSWIRE
Alnylam closes in on phase 3 launch for Regeneron-partnered med
30 Aug 2022 //
FIERCEBIOTECH
07 Dec 2024 //
GLOBENEWSWIRE
30 Aug 2022 //
FIERCEBIOTECH